- California dentist sentenced for sexual battery of patients
- Louisiana lawmakers advance bill to expand Medicaid coverage for dental procedures
- Orthodontics technology company promotes executive leaders
- Premier Care Dental Management’s growth in 2026: 6 moves
- 8 health systems with boosted outlooks
- Managing RCM Disruption with a Strong Patient Payments Strategy
- Why sports partnerships aren’t always home runs for health systems
- Employers are done being quiet about healthcare costs
- Justice Department reclassifies marijuana products: What it means for healthcare
- Southeast Health names CFO successor
- IR Centers, New Jersey Urology to open multiple outpatient centers
- UR Medicine rebrands
- Optum’s turnaround ahead of schedule: Execs
- Justice Department reclassifies marijuana products: What it means for healthcare
- Ozempic pill for children to launch in US market ‘soon’: Novo Nordisk
- Why dental practice owners are feeling a financial squeeze in 2026
- The region seeing a GI boom
- Atropos Health launches medical evidence library
- 5 ASC leaders building the multi-specialty platforms of the future
- Tenet exec pay by the numbers
- What the dental industry can learn from DSO restructurings
- Highest-paid payer CFOs in 2025
- 3 emerging challenges in dentistry
- The employment vs. independence pressure point
- Cincinnati Children’s appoints psychiatry division director
- What is psilocybin? Inside Trump’s push for psychedelic treatments
- Medical real estate developer breaks ground on $16M MOB
- Parkview Dental Partners continues Florida expansion
- What this ASC leader says is driving poor outcomes
- UnityPoint opens CRC clinic in Wisconsin
- ‘The margin quickly goes to zero’: Why cardiology ASC economics are so precarious
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Regeneron to unveil latest 'most favored nation' drug pricing deal with White House
- Roche Q1 earnings suffer blood bath, but currency headwinds aren’t the only culprit
- FDA citizen petition calls on agency to tighten up CRL disclosure practices
- With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- Most Americans Worried About Brain Health, But Few Know How To Protect It
- CMS, FDA announce new program to speed up Medicare coverage of breakthrough medical devices
- ER Study Finds Major Gaps in Measles Immunity
- With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide
- IVF 'Add On' Procedure Doesn't Work, Evidence Review Concludes
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- New Treatment Improves Survival for Aggressive Breast Cancer
- More than 60% of Americans using AI tools for medical information: survey
- Evonik to pump €80M into Slovakia production facility, add 50 jobs
- OpenAI launches ChatGPT for Clinicians, a free AI tool for physicians, NPs and pharmacists
- Deerfield trots into pharma sales software space with CRM-enhancing tool
- Merck’s new AI commercial strategy ‘reimagining engagement with HCPs’
- ‘It buys patients time’: GLP-1s show early promise in addiction treatment
- North American Dental Group appoints vice president of education, development
- Maryland dental assistant sentenced for illegal opioid distribution
- Care New England rolls out Butler Behavioral Health brand
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Grand Canyon University to add 6,000 to behavioral health pipeline
- AMA urges federal oversight of mental health chatbots
- Recovery Unplugged expands virtual outpatient behavioral care to Pennsylvania
- 8 million Americans used psilocybin in past year: Study
- Novant Health, Amae partner on Charlotte behavioral health expansion
- Conservative think tank Paragon Health calls its shots on hospital policy reform
- Amazon One Medical launches GLP-1 program integrated with primary care
- CDC Report on COVID Vaccine Blocked From Publication
- Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
- RFK Jr. continues congressional hearing appearances to talk White House budget plan
- RFK Jr. Won't Commit to CDC Nominee's Vaccine Decisions
- Pentagon Drops Flu Vaccine Requirement For U.S. Military
- AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs
- Zocdoc partners with Yelp to allow real-time scheduling
- CMS delays Part D GLP-1 model amid skepticism from insurers
- CMS delays Part D GLP-1 model amid skepticism from insurers
- Amneal seizes 'golden era' for biosims with $1.1B Kashiv buyout
- Samsung Biologics posts massive revenue growth as labor union rally sets strike in motion
- Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
- Male Infertility Linked To Cancer Risk
- Video Game Training Sharpens ER Doctors’ Split-Second Decisions
- Hidden Belly Fat Linked to Bladder Control in Women
- Mind-Controlled Bionic Suit Lets Paralyzed Patients Feel Every Step
- Napping Linked To Higher Risk Of Death Among Seniors, Study Finds
- Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
- Oak HC/FT backs Courier Health's $50M series B to build out AI for the biopharma patient experience
- Elevance Health seeing shift to bronze tier in ACA plans
- Novartis launches ‘Sjöut for Sjögren’s campaign, teams with Carrie Ann Inaba
- Community Health Systems attributes Q1 volumes stumble to consumers' macroeconomic fears, payers' prior auth denials
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- Merger to create nation's largest suicide prevention nonprofit
- Oz previews new plan to push states toward revalidating Medicaid providers
- Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
- Covera Health, Medmo combine to create end-to-end diagnostic imaging platform
- The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions
- AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win
- In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
- UnitedHealth Group spotlights AI investments as part of operational turnaround
- ECRI spins out healthcare supply chain division into Staritas, backed by PE firm Accel-KKR
- UCB partners with Myasthenia Gravis Foundation of America on meal program targeting nutrition deserts
- Replimune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- 'Hospitals adverse to transparency'—clashing industry groups spar on mulligan 340B rebate pilot
- Amperos Health secures $16M in series A funding, unveils AI-native denial management solution
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- A look inside Highmark and Spring Health's mental well-being partnership
- CVS, Mass General Brigham primary care deal would increase annual care spending by $40M, report predicts
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Why UnitedHealth Group is betting big on doulas
- AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions
- Baby Food Recalled After Rat Poison Discovered in Jar
- Report Finds Drug Prices Rising Despite Trump Pricing Deals
- Trump Backs Psychedelic Research
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
- Physician burnout falls for third year in 2025 to 42%, AMA data shows
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Extra Antibiotic Doesn't Reduce Infection Risk During Surgery To Fix Complex Fractures, Trial Finds
- Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog
- E-Cigarette Taxes Won't Necessarily Cause An Increase In Smoking, Study Says
- Dreams Affect Your Morning Mood In Surprising Ways, Study Finds
- Weed Blunts Brain Development In Teens
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Remarks at the Options Market Structure Roundtable
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Roche’s Enspryng cuts relapse risk by 68% in rare neuroinflammatory disease
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Many of the actions and therapies during the COVID pandemic bypassed normal analysis and approval. Now that the panic has subsided, President Trump believes the public should be informed of what worked and what didn't. Note that President Trump approved Operation Warp Speed, the vaccine acceleration, so he has skin in this game:
https://thehill.com/policy/healthcare/5480506-trump-drugmakers-covid-vaccines-treatment/
Trump demands drugmakers ‘justify’ COVID treatment success
By Tara Suter - September 1, 2025President Trump on Monday demanded drugmakers “justify” the success of their treatments for COVID-19 amid turmoil in his administration over vaccines and other health issues.
“It is very important that the Drug Companies justify the success of their various Covid Drugs. Many people think they are a miracle that saved Millions of lives. Others disagree!” the president said in a post on Truth Social.
“With CDC being ripped apart over this question, I want the answer, and I want it NOW,” the president continued, referring to the Centers for Disease Control and Prevention.
The president ousted the director of the CDC last week amid reports of a showdown between the embattled agency head and Health and Human Services Secretary Robert F. Kennedy Jr. over vaccines.
“I have been shown information from Pfizer, and others, that is extraordinary, but they never seem to show those results to the public. Why not???” Trump wrote Monday. “They go off to the next ‘hunt’ and let everyone rip themselves apart, including Bobby Kennedy Jr. and CDC, trying to figure out the success or failure of the Drug Companies Covid work.”
On Monday, former directors of the CDC rebuked Kennedy, who has a history of vaccine skepticism, over his leadership at the agency and his push to fire its director, Susan Monarez.
In an opinion piece for The New York Times, nine former CDC directors and acting directors offered a warning about the changes Kennedy has made at the agency, which they called alarming.
Demetre Daskalakis, the former leader of the CDC’s National Center for Immunization and Respiratory Diseases, on Thursday said Kennedy had not been briefed by agency experts on measles, COVID-19 and the flu.
“No one from my center has ever briefed him on any of those topics,” Daskalakis said on CNN.
“Perhaps he has alternate experts that he may trust more than the experts at CDC that the rest of the world regards as the best scientists in the areas,” he added.
Trump in his Monday social media post touted the effectiveness of Operation Warp Speed, the push during his first term to speed up vaccine development and distribution during the pandemic. And he said drugmakers “show me GREAT numbers and results, but they don’t seem to be showing them to many others.”
“I want them to show them NOW, to CDC and the public, and clear up this MESS, one way or the other!!! I hope OPERATION WARP SPEED was as ‘BRILLIANT’ as many say it was. If not, we all want to know about it, and why???” he added.
The Hill has reached out to Pfizer for comment.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





